Business Context and Reporting Period
This Form 8-K was filed by Neuralstem, Inc. on November 10, 2015, reporting events occurring on November 9, 2015. The filing serves to announce the Company's financial results for the three and nine months ended September 30, 2015, alongside an update on business and clinical programs.
Key Financial Metrics
The filing text references a press release (Exhibit 99.01) containing specific financial data but does not explicitly state the values within the body of this 8-K. Consequently, the following metrics are not provided in the source text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Investors must refer to the attached Exhibit 99.01 for these specific figures.
Material Changes
The filing does not detail specific numerical changes versus prior periods. It indicates that a business and clinical programs update was issued, but the specific nature of these changes is contained within the referenced press release.
Guidance, Outlook, and Risks
The Company provided a business and clinical programs update as part of the November 9, 2015 announcement. The filing includes a standard disclaimer stating that the information furnished under Item 2.02 and the accompanying press release shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liability of such section.
Important Facts for Investor Verification
- Verify the specific revenue, net loss, and cash position figures in the attached Press Release (Exhibit 99.01), as they are not listed in the 8-K summary text.
- Review the clinical program updates included in the press release to assess the status of the Company's pipeline.
- Note that the financial information in this filing is not deemed "filed" under Section 18 of the Exchange Act, limiting the legal liability associated with the data presented.
- Confirm the reporting period covers the three and nine months ended September 30, 2015.